España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Roche
These Were The Most Actively Traded Securities On OTC Markets In The First Half Of 2020
Sponsored
Pharma Large And Mid-Caps Race Against COVID-19
These Were The Most Active Securities On OTC Markets In April
Sponsored
Pharma Large And Mid-Caps Race Against COVID-19
These Were The Most Active Securities On OTC Markets In April
Sponsored
Roche Receives FDA Emergency Approval To Ship 400,000 Coronavirus Test Kits Across US
What Some Of The Largest Companies On OTC Markets Said In Their Most Recent Earnings Reports
Roche Receives FDA Emergency Approval To Ship 400,000 Coronavirus Test Kits Across US
What Some Of The Largest Companies On OTC Markets Said In Their Most Recent Earnings Reports
The Most Actively Traded Stocks On OTC Markets In July
The First Half Of 2019 On OTC Markets: By The Numbers
Read More...
Roche Recent News
These Were The Most Actively Traded Stocks On The OTC Markets In February
New Gilead Sciences CEO Has 'Breadth Of Experience' From Time At Roche, Says Bullish Raymond James
Novartis' CEO Says Company Open To Selling Its $14 Billion Stake In Roche 'If The Opportunity Were Right'
Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)
Stifel Downgrades InterMune; Roche Offer 'Appropriate Ending'
#PreMarket Primer: Wednesday, July 2: Hopes For A United Iraq Fade
Drugmakers And Superheroes: Who Are The Avengers?
Top Trending Tickers On StockTwits For February 14
Alexion Spikes As Company Hires Goldman Sachs (ALXN)
Morgan Stanley Comments on Higher Bid for Illumina
Oppenheimer Maintains Perform on Illumina After Increased Roche Bid
Auriga Maintains Buy on Illumina After Roche Acquisition Proposal
Goldman Sachs Moves Illumina to Not Rated
Piper Jaffray Maintains Neutral on Illumina After Roche's Tender Offer
Oppenheimer Maintains Perform on Illumina's Proposed Acquisition by Roche
Current Top Percentage Gainers And Losers (XNPT, DGW, IMGN, TPCG, DBLE, GSK, QXM, QTWW, RT, SUPG, NLST)
Pre-Market Top Percentage Gainers and Losers (XNPT, GSK, ZAGG, LOGI, BBBY, PRXL, BLUD, INHX, PWER, INTC, TZOO, KERX)